-
Start Preamble
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on October 28, 2004, Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by renewal and on October 13, 2004 by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed:
Drug Schedule Amphetamine (1100) II Methylphenidate (1724) II Dextropropoxyphene (9273) II Fentanyl (9801) II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.
Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: Federal Register Representative, Office of Liaison and Policy (ODLR) and must be filed no later than March 7, 2005.
Start SignatureStart Printed Page 389End Signature End PreambleDated: December 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 05-72 Filed 1-3-05; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 01/04/2005
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Document Number:
- 05-72
- Pages:
- 388-389 (2 pages)
- PDF File:
- 05-72.pdf